Talisman needle-free CGM demonstrates strong correlation to blood glucose in clinical studies and moves towards large volume manufacturing
17. Juni 2024 02:00 ET
|
GlucoModicum
Talisman needle-free CGM demonstrates strong correlation to blood glucose in clinical studies and moves towards large volume manufacturing Data from Clinical Performance Study of Talisman shows...
GlucoModicum publishes first-in-human data assessing the safety and effectiveness of its MHD technology for accurate needle-free glucose monitoring
09. November 2022 05:12 ET
|
GlucoModicum
GlucoModicum publishes first-in-human data assessing the safety and effectiveness of its MHD technology for accurate needle-free glucose monitoring Human data shows high correlation between...
GlucoModicum Appoints Peter Gerhardsson to its Board of Directors
07. September 2022 02:00 ET
|
GlucoModicum
GlucoModicum Appoints Peter Gerhardsson to its Board of Directors Experienced diabetes executive joins Board following role as Senior Advisor to the Company Helsinki, Finland, 7 September 2022 –...
GlucoModicum publishes data showing integration of MHD technology with ultra-sensitive biosensor enables accurate needle-free glucose monitoring
05. April 2022 02:00 ET
|
GlucoModicum
GlucoModicum publishes data showing integration of MHD technology with ultra-sensitive biosensor enables accurate needle-free glucose monitoring Data published in Biosensors and Bioelectronics...
GlucoModicum and Phillips-Medisize sign a design and development program for the rapid scale-up of its needle-free continuous glucose monitor
29. September 2021 07:00 ET
|
GlucoModicum
PRESS RELEASE GlucoModicum and Phillips-Medisize sign a design and development program for the rapid scale-up of its needle-free continuous glucose monitor Agreement will prepare the Talisman for...
GlucoModicum and Phillips-Medisize sign a design and development program for the rapid scale-up of its needle-free continuous glucose monitor
29. September 2021 02:00 ET
|
GlucoModicum
PRESS RELEASE GlucoModicum and Phillips-Medisize sign a design and development program for the rapid scale-up of its needle-free continuous glucose monitor Agreement will prepare the Talisman for...
GlucoModicum announces the appointment of Peter Gerhardsson as a Senior Advisor
07. September 2021 07:00 ET
|
GlucoModicum
GlucoModicum announces the appointment of Peter Gerhardsson as a Senior Advisor Leading CGM executive with 40 years’ experience working within the medtech and pharmaceutical industries ...
GlucoModicum announces the appointment of Peter Gerhardsson as a Senior Advisor
07. September 2021 02:00 ET
|
GlucoModicum
GlucoModicum announces the appointment of Peter Gerhardsson as a Senior Advisor Leading CGM executive with 40 years’ experience working within the medtech and pharmaceutical industries ...
GlucoModicum’s non-invasive glucose monitoring technology performs 13x better than previous needle-free approaches
20. April 2021 02:00 ET
|
GlucoModicum
GlucoModicum’s non-invasive glucose monitoring technology performs 13x better than previous needle-free approaches - Data published in Scientific Reports, part of the Nature Portfolio Journals,...